Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Research
Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Focus on Computer Resources
      • Highly Cited Collection
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Early Career Award
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citations
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Experimental Therapeutics, Molecular Targets, and Chemical Biology

Sensitization of Mesothelioma Cells to Tumor Necrosis Factor–Related Apoptosis–Inducing Ligand–Induced Apoptosis by Heat Stress via the Inhibition of the 3-Phosphoinositide-Dependent Kinase 1/Akt Pathway

Melissa H. Pespeni, Maki Hodnett, Keith S. Abayasiriwardana, Jérémie Roux, Marybeth Howard, V. Courtney Broaddus and Jean-François Pittet
Melissa H. Pespeni
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maki Hodnett
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Keith S. Abayasiriwardana
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jérémie Roux
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marybeth Howard
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
V. Courtney Broaddus
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jean-François Pittet
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/0008-5472.CAN-06-3871 Published March 2007
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Heat stress potentiates apoptosis due to TRAIL, but not to chemotherapeutic agents, in malignant mesothelioma cells. A, heat stress (43°C for 60 min, recovery 60 min) enhances apoptosis due to TRAIL (1 or 2.5 ng/mL for 20 h) in M28 mesothelioma cells. Heat stress had no effect on apoptosis due to the ribotoxic agent anisomycin or to the DNA damaging agents etoposide, gemcitabine, or cisplatin. B, after activation of SPR by heat, the potentiation of apoptosis was maximal when TRAIL (1 ng/mL for 8 h) was added after a 1-h recovery and was still present after a 12-h recovery. C, in primary nonmalignant human mesothelial cells, heat stress (HS) had no effect on subsequent apoptosis due to TRAIL (1 ng/mL for 8 h). Columns, mean of at least three experiments done in triplicate; bars, SE. *, P < 0.05 versus TRAIL alone.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Role of PI3K/Akt in the potentiation of TRAIL-induced apoptosis by heat stress. A, the high baseline expression of p-Akt in M28 mesothelioma cells [phospho-Akt (Ser473)] is decreased at the end of heat stress. One representative experiment. Columns, mean of three experiments; bars, SE. *, P < 0.05 versus control. B, activation of SPR by heat also significantly inhibits the phosphorylation of p70S6K, a kinase downstream of Akt, measured at the end of heat stress. One representative experiment. Columns, mean of three experiments; bars, SE. *, P < 0.05 versus control. C, LY294002 (50 μmol/L for 1 h) significantly inhibits the high constitutive Akt phosphorylation in M28 mesothelioma cells. One representative experiment. Columns, mean of three experiments; bars, SE. *, P < 0.05 versus control. D, TRAIL alone (1 ng/mL for 8 h) induces minimal apoptosis in M28 mesothelioma cells. However, pretreatment with LY294002 (50 μmol/L for 1 h) or heat stress enhances the effect of TRAIL (1 ng/mL for 8 h). Columns, mean of three experiments done in triplicate; bars, SE. *, P < 0.05 versus TRAIL alone.

  • Figure 3.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3.

    Heat stress and 17-AAG dissociate Hsp90 from PDK-1. A, M28 mesothelioma cells exposed to heat stress (43°C for 60 min, recovery 60 min) were subjected to lysis and immunoprecipitation (IP) with an antibody specific for PDK-1. The resultant immunoprecipitates were then examined via immunoblotting (IB) for Hsp90 and PDK-1. At baseline, PDK-1 associated with Hsp90. At 1 h after heat stress, the PDK-1 has mostly dissociated from Hsp90. In the absence of antibody, no nonspecific association is seen. One representative experiment of three. Columns, mean of at least three experiments; bars, SE. *, P < 0.05 versus no heat stress control. B, 17-AAG leads to a dissociation of Hsp90 from the PDK-1. M28 cells were exposed to 17-AAG (1 μg/mL for 1 h) and subjected to lysis and immunoprecipitation with an antibody specific for PDK-1. The resultant immunoprecipitates then were examined via immunoblotting for Hsp90 and PDK-1. One representative experiment. Columns, mean of three experiments; bars, SE. *, P < 0.05 versus controls. C, pretreatment with 17-AAG (2 μg/mL for 1 h) significantly decreases p-Akt. One representative experiment. Columns, mean of three experiments; bars, SE. *, P < 0.05 versus controls. D, TRAIL alone (1 ng/mL for 8 h) induces minimal apoptosis in M28 mesothelioma cells. However, 17-AAG (1 μg/mL) enhances the apoptosis due to TRAIL (1 ng/mL for 8 h). Columns, mean of three experiments done in triplicate; bars, SE. *, P < 0.05 versus TRAIL alone.

  • Figure 4.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 4.

    A constitutively active PDK-1 (CA-PDK-1) maintains Akt activity, thereby blocking the ability of heat stress or 17-AAG to potentiate TRAIL-induced apoptosis. A, M28 mesothelioma cells were subjected to mock transfection or transfection with a constitutively active PDK-1 plasmid. Forty-eight hours later, the cells were exposed to 17-AAG (1 μg/mL for 1 h). The active PDK-1 was able to prevent the decrease in p-Akt seen with 17-AAG. B, transfection of M28 cells with constitutively active PDK-1 prevented the ability of heat stress or 17-AAG (1 μg/mL for 8 h) to potentiate TRAIL-induced apoptosis. Columns, mean of three experiments done in triplicate; bars, SE. *, P < 0.05 versus TRAIL alone; **, P < 0.05 versus controls without constitutively active PDK-1.

  • Figure 5.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 5.

    Heat stress increases TRAIL-induced caspase 8 and Bid cleavage and decreases the expression of c-FLIP. A and B, M28 mesothelioma cells were exposed to heat stress (43°C for 60 min, recovery 60 min) followed by no treatment for 7 h or TRAIL (1 ng/mL) for 4 or 7 h. Heat stress led to an increase in TRAIL-induced caspase 8 cleavage as judged by an increased detection of the large 43-kDa fragment of caspase 8. In addition, heat stress induced an increase of the TRAIL-induced cleavage of Bid, as judged by a decrease in whole Bid. Actin was used as a standard to confirm equivalent protein loading. One representative experiment. Columns, mean of at least three experiments; bars, SE. *, P < 0.05 versus TRAIL alone. C, heat stress (43°C for 60 min, recovery 60 min) decreases expression of c-FLIP. One representative experiment. Columns, mean of at least three experiments; bars, SE. *, P < 0.05 versus controls.

  • Figure 6.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 6.

    Heat stress requires Bid for full potentiation of TRAIL-induced apoptosis. A, M28 mesothelioma cells were transfected with either random or Bid-specific small interfering RNAs, showing almost complete inhibition of Bid protein expression by Bid-specific small interfering RNA at 48 h after transfection. B, M28 cells transfected 48 h previously with Bid-specific or random small interfering RNA were exposed to heat stress and TRAIL. The absence of Bid inhibited the effect of heat stress on subsequent TRAIL-induced apoptosis. Columns, mean of at least three experiments done in triplicate; bars, SE. *, P < 0.05 versus cells transfected with the random small interfering RNA.

PreviousNext
Back to top
Cancer Research: 67 (6)
March 2007
Volume 67, Issue 6
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Sensitization of Mesothelioma Cells to Tumor Necrosis Factor–Related Apoptosis–Inducing Ligand–Induced Apoptosis by Heat Stress via the Inhibition of the 3-Phosphoinositide-Dependent Kinase 1/Akt Pathway
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Sensitization of Mesothelioma Cells to Tumor Necrosis Factor–Related Apoptosis–Inducing Ligand–Induced Apoptosis by Heat Stress via the Inhibition of the 3-Phosphoinositide-Dependent Kinase 1/Akt Pathway
Melissa H. Pespeni, Maki Hodnett, Keith S. Abayasiriwardana, Jérémie Roux, Marybeth Howard, V. Courtney Broaddus and Jean-François Pittet
Cancer Res March 15 2007 (67) (6) 2865-2871; DOI: 10.1158/0008-5472.CAN-06-3871

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Sensitization of Mesothelioma Cells to Tumor Necrosis Factor–Related Apoptosis–Inducing Ligand–Induced Apoptosis by Heat Stress via the Inhibition of the 3-Phosphoinositide-Dependent Kinase 1/Akt Pathway
Melissa H. Pespeni, Maki Hodnett, Keith S. Abayasiriwardana, Jérémie Roux, Marybeth Howard, V. Courtney Broaddus and Jean-François Pittet
Cancer Res March 15 2007 (67) (6) 2865-2871; DOI: 10.1158/0008-5472.CAN-06-3871
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • Trastuzumab and Pertuzumab: Enhanced Antitumor Activity
  • Imatinib Sensitizes Bcr-Abl+ Cells to Cisplatin
  • Loss of S1P Lyase Upregulates Bcl-2
Show more Experimental Therapeutics, Molecular Targets, and Chemical Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement